Inside information, profit warning: Optomed receives a large order in the US and increases its full year outlook
Reading Time: < 1 minute Optomed Plc Inside Information 11 November 2024 at 21.00, Helsinki Inside information, profit warning: Optomed receives a large order in the US and increases its full year outlook Optomed has received a EUR 1.5 million order and increases its full
ALEXANDRIA GROUP OYJ: ACQUISITION OF OWN SHARES 11.11.2024
Reading Time: < 1 minute ALEXANDRIA GROUP OYJ NOTIFICATION 11.11.2024 at 18:30 EET ALEXANDRIA GROUP OYJ: ACQUISITION OF OWN SHARES 11.11.2024 Date 11.11.2024 Exchange transaction Buy Share class ALEX Amount 250 Average price/share 8.4500 EUR Highest
#24-387 Listing of Derivatives at NGM
Reading Time: < 1 minute Information about various derivatives that will be listed at NGM. For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGM Nordic Growth Market
Orkla ASA: Mandatory notification of trade – options
Reading Time: < 1 minute Reference is made to the previous stock exchange release on 31 October 2024 regarding exercise of share options by primary insider Christer Grönberg under Orkla ASA’s long term share incentive programme. The sales process conducted by a third party is
L&T Technology Services Deepens Software Product Development, Platform Engineering & AI Expertise
Reading Time: 2 minutes California, San Francisco, United States & Bangalore, Karnataka, India: Signs definitive agreement to acquire California based Intelliswift Expands footprint in Hyperscalers and big tech spenders L&T Technology Services Limited (BSE: 540115, NSE: LTTS), a global
Wärtsilä President & CEO Håkan Agnevall on sick leave until 25 November
Reading Time: < 1 minute Wärtsilä Corporation, Stock exchange release, 11 November 2024 at 17.00 EET Wärtsilä President & CEO Håkan Agnevall on sick leave until 25 November Wärtsilä’s President & CEO Håkan Agnevall will be on sick leave due to a planned routine surgery
Kesko Corporation: Disclosure in compliance with Chapter 9, Section 10 of the Finnish Securities Markets Act (08.11.2024)
Reading Time: 2 minutes Kesko Corporation has on 11 November 2024 received a notification pursuant to Chapter 9, Section 10 of the Finnish Securities Markets Act from BlackRock, Inc. According to the notification, on 8 November 2024, BlackRock, Inc.’s holding in Kesko Corporation, including holding
Megaport Launches in Brazil, Bringing Industry-Leading Global Network to South America
Reading Time: 3 minutes Brisbane, Australia: Megaport Limited (ASX: MP1) (“Megaport”), the global leading Network as a Service (NaaS) provider, announces its official expansion into Brazil, establishing its connectivity services in São Paulo. This expansion enables enterprises to securely connect locally and globally between 860+
Norconsult ASA: Settlement of Employee Share Program 2023 (“Gift Shares”)
Reading Time: 4 minutes Sandvika, 11 November 2024 (OSE: NORCO): Reference is made to the announcement by Norconsult ASA (the “Company”) regarding the Employee Share Program (the “Share Program”) described in the announcement from 10 November 2023 in connection with the Company’s first day of
Biocytogen Announces IDEAYA’s Nomination of Development Candidate IDE034, a Potential First-in-Class B7H3/PTK7 Topo-I-Payload Bispecific ADC and Option Exercise
Reading Time: 3 minutes Beijing, China & South San Francisco, Calif., United States: IDEAYA has exercised the option for an exclusive worldwide license on Biocytogen’s potential first-in-class B7H3/PTK7 topo-I-payload bispecific antibody-drug conjugate (BsADC), BCG034 (IDE034) This milestone further validates Biocytogen’s proprietary RenLite® antibody